Guest: Timothy Yap, MBBS, PhD, FRCP <br>


  <p>As DNA damage response therapies move beyond PARP inhibitors, what do we need to know? Dr. Timothy Yap from the University of Texas MD Anderson Cancer Center shares insights and takeaways from his presentation at the 2021 San Antonio Breast Cancer Symposium.</p>

Guest: Timothy Yap, MBBS, PhD, FRCP As DNA damage response therapies move beyond PARP inhibitors, what do we need to know? Dr. Timothy Yap from the University of Texas MD Anderson Cancer Center shares insights and takeaways from his presentation at the 2021 San Antonio Breast Cancer Symposium.

Targeting the DNA Damage Response: Updates from the 2021 SABCS

Showcasing major breakthroughs in cancer care from worldwide clinical trials, Project Oncology® educates and assists the healthcare professionals who dedicate their lives to helping patients fight cancer.
Here you’ll find leading oncologists discuss and share essential cancer care strategies for all different types of cancer. And as worldwide clinical trials continue to explore new screening tests and discover novel treatment options, you can rest assured that you’ll always catch the latest in cancer research with Project Oncology®.

Medicine

Showcasing major breakthroughs in cancer care from worldwide clinical trials, Project Oncology® educates and assists the healthcare professionals who dedicate their lives to helping patients fight cancer. Here you’ll find leading oncologists discuss and share essential cancer care strategies for all different types of cancer. And as worldwide clinical trials continue to explore new screening tests and discover novel treatment options, you can rest assured that you’ll always catch the latest in cancer research with Project Oncology®.

Showcasing major breakthroughs in cancer care from worldwide clinical trials, Project Oncology®&nbsp;educates and assists the healthcare professionals who dedicate their lives to helping patients fight cancer.
Here you’ll find leading oncologists discuss and share essential cancer care strategies for all different types of cancer. And as worldwide clinical trials continue to explore new screening tests and discover novel treatment options, you can rest assured that you’ll always catch the latest in cancer research with Project Oncology®.

Share Targeting the DNA Damage Response: Updates from the 2021 SABCS

Sign up to save your podcasts

Targeting the DNA Damage Response: Updates from the 2021 SABCS

Targeting the DNA Damage Response: Updates from the 2021 SABCS

More shows like Project Oncology®

Journal of Clinical Oncology (JCO) Podcast

PeerView Oncology & Hematology CME/CNE/CPE Video Podcast

ASCO Daily News

Core IM | Internal Medicine Podcast

Two Onc Docs

Oncology Brothers: Practice-Changing Cancer Discussions

CME in Minutes: Education in Oncology & Hematology